American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call on March 31, 2026, at 12:00 PM ET to discuss its fourth quarter and full year 2025 financial results. The financial results press release will be issued before the market opens on the same day.
The conference call will be accessible to domestic callers at 1-844-413-3972 and international callers at 1-412-317-5776, with participants asked to dial in at least 10 minutes prior to the start. A simultaneous webcast will be available through the Company's website at www.ashs.com or directly via this link. A replay of the call will be available from 1-855-669-9658 or 1-412-317-0088, using access code 6331493, through April 7, 2026, and will also be archived on the Company's website.
American Shared Hospital Services (AMS) provides turnkey solutions to cancer treatment centers, health systems, and cancer networks in North and South America. The company collaborates with partners to develop and grow cancer service lines, offering integrated cancer care in local settings. Under health system partnerships, AMS and its partners share capital investment costs and profitability based on ownership interests. This financial report is significant as it will shed light on the company's performance amid ongoing expansion in Gamma Knife, proton therapy, and advanced radiation therapy services.
The announcement comes at a critical time for the oncology services sector, where technological advancements and reimbursement changes are shaping the landscape. Investors and stakeholders will be keen to assess the company's financial health and strategic direction, particularly given the risks highlighted in the safe harbor statement, including variability in financial results, changes in CMS reimbursement rates, and the challenges of expanding into new markets. The company's forward-looking statements emphasize expectations for continued growth, but also acknowledge potential risks that could affect outcomes.
The conference call will provide an opportunity for analysts and investors to engage with management, including Executive Chairman and CEO Ray Stachowiak, who will discuss the results and answer questions. The company's filings with the Securities and Exchange Commission, including its Quarterly Report on Form 10-Q for periods ended March 31, 2025, June 30, 2025, September 30, 2025, and the Annual Report on Form 10-K for the year ended December 31, 2024, contain further information on potential factors affecting the company's financial condition and future plans.
